- Home
- WRAP vs ANVS Comparison
WRAP vs ANVS Comparison
Compare WRAP & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRAP
- ANVS
- Stock Information
- Founded
- WRAP 2016
- ANVS 2008
- Country
- WRAP United States
- ANVS United States
- Employees
- WRAP N/A
- ANVS N/A
- Industry
- WRAP Ordnance And Accessories
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- WRAP Industrials
- ANVS Health Care
- Exchange
- WRAP Nasdaq
- ANVS Nasdaq
- Market Cap
- WRAP 68.8M
- ANVS 110.4M
- IPO Year
- WRAP N/A
- ANVS 2020
- Fundamental
- Price
- WRAP $1.70
- ANVS $9.64
- Analyst Decision
- WRAP
- ANVS Strong Buy
- Analyst Count
- WRAP 0
- ANVS 6
- Target Price
- WRAP N/A
- ANVS $29.67
- AVG Volume (30 Days)
- WRAP 191.1K
- ANVS 341.4K
- Earning Date
- WRAP 10-15-2024
- ANVS 11-06-2024
- Dividend Yield
- WRAP N/A
- ANVS N/A
- EPS Growth
- WRAP N/A
- ANVS N/A
- EPS
- WRAP N/A
- ANVS N/A
- Revenue
- WRAP $7,269,000.00
- ANVS N/A
- Revenue This Year
- WRAP N/A
- ANVS N/A
- Revenue Next Year
- WRAP N/A
- ANVS N/A
- P/E Ratio
- WRAP N/A
- ANVS N/A
- Revenue Growth
- WRAP 0.99
- ANVS N/A
- 52 Week Low
- WRAP $1.21
- ANVS $4.53
- 52 Week High
- WRAP $7.01
- ANVS $22.49
- Technical
- Relative Strength Index (RSI)
- WRAP 56.79
- ANVS 58.70
- Support Level
- WRAP $1.71
- ANVS $9.00
- Resistance Level
- WRAP $1.93
- ANVS $10.54
- Average True Range (ATR)
- WRAP 0.16
- ANVS 0.81
- MACD
- WRAP 0.01
- ANVS 0.12
- Stochastic Oscillator
- WRAP 61.70
- ANVS 74.57
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc offers public safety technologies and services. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.